::: Huons :::

2020s

2024-12 Incorporation of the PanGen subsidiary
2024-11 Completion of Gwacheon Huons Dong-Am R&D Center
2024-04 Huons subsidiary 'Crystal Life Sciences' changes name to 'Huons Life Sciences'
2024-01 Huons Approves Phase 1 IND of "HUC1-394" for dry eye disease
2023-12 Incorporation of 'Crystal Life Sciences' subsidiary
2023-06 Huons wins FDA approval for local anesthetic '2% lidocaine'
2023-02 A lactobacillus for women's menopause 'Menolacto' Sales surpassed 100 Billion won
2022-01 Establishment of Huons Foodience (Merger of Huons Nature-Huons Natural)
2021-12 Acquisition of integrated certification for safety and health management system.
2021-07 Moved to Pangyo 2nd Techno Valley
2021-06 Decides to give stock options
2021-06 Huons Founds PBA Professional Billiards Huons Healthcare Legend
2020-12 Signed a technology transfer contract for stress functional materials with Aju University
2020-11 Promotion of Construction of Plant 2 for Eye drop
2020-11 Signed MOU for Joint Research on Antiviruses with Korea University Medical Center
2020-10 Awarded for Lactobacillus with New Technology and Dairy Technology YT1 by the Ministry of Agriculture
2020-10 Supplied National Essential Medicines Humetrine
2020-10 Domestic Launch of Dexcom G6
2020-09 HUTOX registered in Iraq.
2020-09 Obtained Saudi Patent for Nanocomposite Shop Proposal
2020-08 Signed a technology transfer agreement for Dry Eye with Novacell Technology
2020-08 Export ClassGen Eye Drops to Saudi Arabia (domestic name : Clacier eye drop)
2020-07 Export 1% Lidocaine Injection 5ml (vial) to the USA
2020-06 Supplied Covid-19 Masks to the Washington State
2020-06 Domestic Launch of Gasfamo
2020-05 FDA Permission to Lidocaine Injection Vial
2020-04 Domestic Launch of Doublo Fill
2020-04 Domestic Launch of Elruby Menolacto Probiotics
2020-03 Signed COVID-19 Diagnosis Reagent MOU with GENCURIX. CE certified.
2020-02 Domestic Launch of Varrerderm MD
2020-01 Obtained approval of FDA-ANDA for 0.75% Bupivacaine hydrochloride

2010s

2019-11 Patent Acquisition of Lactobacillus Coating Technology
2019-11 Domestic Launch of Eszopiclone
2019-11 Patent Acquisition of Low Viscosity Technology
2019-11 Signed a Sales Contract with Insitech
2019-10 Patent Acquisition of Nanocomposite eye drop in Japan
2019-09 Patent Acquisition of Nanocomposite eye drop in 6 Europe countries, Russia and Indonesia.
2019-08 Signed Exclusive License and Investment Contracts with Prestige BioPharma
2019-08 Domestic Launch of Merit C&D
2019-07 Signed Joint Research and Development Agreement on Electronic Pharmaceuticals with NUEYNE
2019-07 Signed Food & Drug Development and Business Cooperation Agreement with Honcheon Medical Hub Laboratory
2019-07 Huonland has received approval for its HA eye drop(0.3%, 0.8ml) from the CFDA.
2019-05 Signed a MOU for new medicine development based on AI system with DR.NOAH Biotech.Co.,Ltd.
2019-05 Hosted The Second Annual Huons Elravie Celebrity Pro-Am
2019-01 Sung Shin B.S.T. changed name to "Huons Nature"
2019-01 Awarded with "Job Creation" award by the Ministry of Employment and Labor
2018-11 Accredited ISO 37001 to prevent illegal rebates and organizational corruption
2018-10 Hosted The First Annual Huons Celebrity Pro-Am
2018-06 Acquired health functional food(Korean Ginseng) company ‘Sung Shin B.S.T.’
2018-05 Signed sponsor partnership agreement with welfare facility in Seongnam city
2018-05 Awarded a citation by the Prime Minister of the 2018 Equal Employment Ceremony
2018-04 1% Lidocaine Injection 5ml Amp. approved by the U.S. FDA
2018-03 Launched professional ladies golf team
2017-12 Awarded a presidential citation from Korea New Growth Management Awards 2018.
2017-10 Awarded top 10 great KOSDAQ companies from Korea IR Awards 2017
2017-07 Sodium chloride injection(0.9%) approved by the U.S. FDA
2017-04 Fermented Honeybush Extract Powder’ was approved as a functional ingredient by Ministry of Food and Drug Safety
2017-02 Signed partnership agreement with KIST(Korea Institute of Science and Technology) Gangneung branch
2016-09 Acquired bio company ‘Biotopia’
2016-08 Cheong Ho Natural changed name to Huons Natural
2016-08 Change to holding company - Huons Global
2016-06 Relisted on KOSDAQ
2016-05 Spinoff
2016-05 Acquired Food·health functional food company ‘Cheong Ho Natural’
2015-12 Designated as an excellent family-friendly corporation by Ministry of Gender Equality and Family
2015-11 Awarded with a commendation from Ministry of Commerce, Industry and Energy (excellent employment)
2015-11 Awarded EY outstanding entrepreneurship award
2015-07 50 years since the establishment
2015-01 Opening Huons Daycare center for childeren
2014-09 Awarded with labor-management culture award by the Ministry of Employment and Labor
2014-05 Designated as a World-Class 300
2013-12 Designated as a Good work place in Gyeonggi-province
2012-12 Awarded the industry contribution award
2011-12 Awarded with $10 million Export
2011-11 Strategic alliance with Alcon Co., . (Kynex 2)
2011-02 Acquisition of INNO-BIZ certification
2010-07 Acquired equity in KRD, co.
2010-01 Acquired equity in Humedics, co.

2000s

2009-10 KGMP accredited for the factory in Jecheon
2009-03 Sodium chloride injection approved by the U.S. FDA (510K)
2008-12 Hubena, co. combined as a subsidiary
2007-12 Received a citation in recognition of corporate social responsibility
2006-12 Listed on KOSDAQ
2006-10 Received a citation by the Prime Minister
2004-11 Received a national award in recognition of $5M value export performance
2003-08 ISO9001 accredited
2003-06 Huons, co. renamed
2002-02 Received a citation by the Minister of Health and Welfare
2000-08 Appointed as an outstanding venture firm

1990s

1999-01 Kwangmyung Phamaceutical Co. renamed
1998-12 Developed plastic injection container for the first time in Korea (Patent Registration 0381404)
1998-05 Corporate R&D center founded
1993-12 KGMP(Outstanding medical products and quality management) accredited

1980s

1987-08 Conversion to a corporation Kwang Myung Pharm

1960s

1965-07 Established Kwang Myung Pharmaceutical Company